Skip to main content

Table 4 Other costs before and after starting the insulin treatment

From: Total costs of basal or premixed insulin treatment in 5077 insulin-naïve type 2 diabetes patients: register-based observational study in clinical practice

  Pre-index Post-index Increment Net cost effect
  Health care Treatment Health care Treatment Health care Treatment
Treatment Mean/Median Mean/Median Mean/Median Mean/Median Mean/Median Mean/Median Mean/Median
NPH 25,417/9,215 5,209/2,445 24,173/10,439 6,287/2,926 −1,244/755 1,078/125 −166/880
IG 23,533/10,341 5,576/2,784 28,096/12,447 7,063/3,267 4,563/1,225 1,486/224 6,049/1,449
ID 20,297/9,205 4,515/1,455 22,313/10,652 5,300/1,819 2,016/1,717 785/160 2,801/1,877
PM 28,423/10,752 6,380/3,150 26,880/12,191 7,549/3,877 −1,543/883 1,169/283 −374/1,166
p-values 0.0054 <0.00001 0.0010 <0.00001 0.55 0.052  
  1. NPH Neutral protamine Hagedorn, IG insulin glargine, ID insulin determir, PM premixed insulin, SD standard deviation. The approximate value of 100 SEK is currently 12 US dollars (August 2015)